CIS
GRCL

Capital International Sarl’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Capital International Sarl’s Portfolio GRCL Stock Details GRCL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$684K Sell
2022
Q3 		$981K Buy
2022
Q2 		$1.66M Buy
2022
Q1 		$532K Buy
2021
Q4 		$1.33M Buy
2021
Q3 		$2.21M Buy
2021
Q2 		$1.87M Buy
2021
Q1 		$2.05M Buy